http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6299323-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4065dce161c01afdeb8011ae34a93f65
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 1985-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3ce5116d0c21c10073e168bdeaf00e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac846d07acaadb964b5229b3aaf4040c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57dcf99869244c5348f14f6803f75563
publicationDate 1987-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6299323-A
titleOfInvention Agent for hyperlipemia
abstract PURPOSE:An agent for hyperlipemia useful for various diseases caused by lipid metabolism disorder, having no toxicity, capable of being administered for a long period, showing improved cholesterol lowering action, containing hexacosanol of a higher fatty alcohol as an active ingredient. CONSTITUTION:An agent for hyperlipemia containing hexacosanol as an active ingredient. Hexacosanol shows improved cholesterol lower action on serum cholesterol, liver cholesterol and no side effect such as gastrointestinal disorder, etc. Addition of another anti-lepemia component such as beta-sitosterol may show synergistic effects. This agent is useful for preventing and remedying diseases related to lipid metabolism disorder such as hypertension, arteriosclerosis, cerebral infarct, etc.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1108364-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1108365-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006282655-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0488928-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06192072-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012518639-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007063203-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6328998-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6875443-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1177729-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1177729-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007091672-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1121928-A1
priorityDate 1985-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68171
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406106

Total number of triples: 45.